Showing results (21-30 of 534) with videos related to
Sort By:
Pageof 54
Expert Opinion on Drug Metabolism & Toxicology|March 4, 2014
Pharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosisRadu Tanasescu, Cris S ConstantinescuImmunobiology|September 22, 2009
Cannabinoids and experimental models of multiple sclerosisIlona Kubajewska, Cris S ConstantinescuCurrent Neurology and Neuroscience Reports|July 12, 2012
Cost-effectiveness of disease-modifying therapies in multiple sclerosisAli Manouchehrinia, Cris S ConstantinescuCurrent Eye Research|December 28, 1999
Anterior uveitis in murine relapsing experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS)C S Constantinescu, E LaviRomanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie|July 1, 1994
Interference of some enzymatic modulators in the hepatic aggression induced by xenobioticsG Filipescu, E Codorean, C Tănase, et al.Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie|January 1, 1991
Morphological and biochemical characteristics in the experimentally treated rats with indigenous synthetical products used as pesticidesG Filipescu, E Codorean, D Laky, et al.Neurorehabilitation and Neural Repair|April 12, 2002
Possible role of corticosteroids in nervous system plasticity: improvement in amblyopia after optic neuritis in the fellow eye treated with steroidsC S Constantinescu, I GottlobImmunobiology|February 16, 2010
Cannabinoids and the immune system: an overviewRadu Tanasescu, Cris S ConstantinescuExpert Opinion on Drug Metabolism & Toxicology|April 30, 2013
Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis painRadu Tanasescu, Cris S ConstantinescuNeurodegenerative Disease Management|February 26, 2015
What role does tobacco smoking play in multiple sclerosis disability and mortality? A review of the evidenceMikail Weston, Cris S ConstantinescuPageof 54